Follow The Filings

RCKT Rocket Pharmaceuticals

Rocket Pharmaceuticals earnings company data as of 1:01 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by RCKT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RCKT insider trades
  • $34K bought by 1 insider
  • $34K sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Elisabeth Bjork Director
    Buy
    $34K 10,000 shares at $3.44 +25% to stake
    Traded Jan 2 Filed Jan 6
    ↗
  2. John Militello See Remarks
    Sale
    $3,240 1,086 shares at $2.98 1.6% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
    ↗
  3. Jonathan David Schwartz See Remarks
    Sale
    $7,592 2,545 shares at $2.98 0.8% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
    ↗
  4. Gaurav Shah CEO
    Sale
    $19K 6,276 shares at $2.98 0.8% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
    ↗
  5. Martin Wilson General Counsel
    Sale
    $4,910 1,646 shares at $2.98 0.4% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
    ↗
  6. John Militello See Remarks
    Sale
    $115K 28,918 shares at $3.96 30% of stake
    Traded Oct 14, 2025 Filed Oct 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 sales to cover taxes, 14 stock grants, 1 other transaction, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 1.01,2.03,3.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
8-K 2.01,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.